Tumor avatars could personalize chemo for kids with rare cancers
NCT ID NCT07528079
First seen Apr 19, 2026 · Last updated Apr 25, 2026 · Updated 1 time
Summary
This study tests a new way to choose chemotherapy for children aged 1 to 18 with hard-to-treat soft tissue sarcomas. Doctors will grow a miniature version of each child's tumor in the lab and test different drugs on it to find the most effective one. The goal is to see if this personalized approach leads to better tumor shrinkage and longer control of the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA, CHILD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200127, China
Conditions
Explore the condition pages connected to this study.